Definitive Contract IND15PC00035

Award Date 2/25/15
Potential Completion Date 4/29/16
Potential Value $150K
Contracting Federal Agency
Interior Business Center
Ultimate Awardee
Zymergen Inc.
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02142, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
62
Legislative Mandate
Economy Act
National Interest Action
Not listed
Research Type
STTR Phase I
Primary Consortia Member
Not listed
Similar Awards
The Department of Defense awarded a $999,998 Small Business Technology Transfer (STTR) Phase II contract to Synvitrobio, Inc. (doing business as Tierra Biosciences) for the development of allosteric transcription factor biosensors. Synvitrobio is a minority-owned, for-profit synthetic biology company that specializes in biosystems identification and cell-free protein synthesis services for government customers. The contract, which has a firm fixed price structure, supports the Research,...
The Environmental Protection Agency (EPA) Office of Research and Development awarded a firm-fixed-price purchase order to Attagene Inc., a self-certified small disadvantaged business, for Transcription Factor Profiling services. The $187,771.60 contract supports the development of transcription factor activity profiling signatures to assess the biological impacts of chemicals. Attagene has previously provided environmental water sample analysis and transcription factor profiling services to...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Lifesensors Inc., doing business as Gene Transcription TECH. The contract is for applied/exploratory biomedical research, with a ceiling value of $149,550 and a period of performance through March 30, 2010. Lifesensors is a biotechnology company that conducts research on novel therapeutic approaches such as targeted...
This is a firm-fixed-price delivery order contract awarded by the U.S. Environmental Protection Agency (EPA) to Attagene Inc., a small disadvantaged business. The contract, valued at $220,054.20, is for "Multiplexed Transcription Factor Profiling of the ToxCast Compound Library," which supports the EPA's ToxCast prioritization program. Attagene will provide bioanalytical services to assess the biological impacts of chemicals using transcription factor activity profiling. This work...
This is a $84,369.70 firm fixed-price delivery order contract awarded by the Environmental Protection Agency's Office of Research and Development to Attagene Inc., a small disadvantaged business, for "Multiplexed Transcription Factor Profiling of the ToxCast Library." The contract is part of the ToxCast prioritization program and involves analyzing the transcriptional responses of chemical compounds in the ToxCast library. Attagene has previously conducted similar transcription...
This is a Firm Fixed Price Delivery Order contract awarded by the U.S. Environmental Protection Agency's Office of Research and Development to Attagene Inc., a small disadvantaged business, for $111,360.00. The contract is for "Multiplexed Transcription Factor Profiling of the ToxCast Compound Library", which supports the EPA's ToxCast prioritization program by using Attagene's expertise in transcription factor profiling to assess the biological impacts of chemicals. Attagene has...
The U.S. Department of Health and Human Services (HHS) awarded a $142,932 Small Business Innovation Research (SBIR) Phase I contract to Active Motif, Inc., a small disadvantaged business, to develop a commercial kit to enable academic and clinical researchers to evaluate locus-specific methylation across a wide range of disease models. This SBIR contract, awarded on September 30, 2009, has a completion date of March 31, 2010. Active Motif is a leading provider of tools for epigenetics and gene...
Molecular Devices LLC was awarded a definitive contract valued at $658,099 by the National Institutes of Health National Institute on Drug Abuse to deliver one Molecular Devices FLIPR Penta high-throughput cellular screening system. The firm fixed price contract runs from September 24, 2020 through March 24, 2021. The prime contractor, Molecular Devices LLC, a division of Danaher Corporation, will provide the requested products and services to the NIH campus in Rockville, Maryland. The...
This is a firm fixed-price delivery order under the TOXCAST PRIORITIZATION program, awarded by the Environmental Protection Agency's (EPA) Office of Research and Development to Attagene Inc., a small disadvantaged business. The contract, valued at $100,224.00, requires Attagene to perform multiplexed transcription factor profiling of the TOXCAST compound library. This work supports the EPA's efforts to develop improved approaches for assessing the biological impacts of chemicals, with...
This federal contract award, valued at $31,900.00, was issued by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Active Motif, Inc., a small disadvantaged business. The contract provides "FACTOR PATH ANALYSIS SERVICE" with a completion date of March 29, 2023. The work is related to a pre-solicitation opportunity focused on using ChIP-seq (Chromatin Immunoprecipitation Sequencing) and other genomic research techniques to map cell signaling pathways...

PROGRAMMABLE ALLOSTERIC TRANSCRIPTION FACTORS AS SPECIFIC MOLECULAR SENSOR - ACTUATORS.

Posted 2/12/15, 12:00 AM